Assessment the effect of green tea and wheat bran on metabolic syndrome

Assessment the effect of green tea and wheat bran on diagnostic indicators of metabolic syndrome in Shahroud drivers in 2020

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200217046524N1

Enrollment

Registered

2020-05-25

Start date

2020-03-20

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome. Metabolic syndrome

Interventions

Intervention 1: First intervention group: Green Tea- To the Green Tea Group will be recommended 3 cups of simple green teabag (one gram) daily from without added sugar or milk for 2 months. There will

Eligibility

Sex/Gender

All

Age

40 Years to 50 Years

Inclusion criteria

Inclusion criteria: Satisfaction to participate in the study Existence driver's health record Metabolic syndrome based on ATP definition Age range 40 to 50 years

Exclusion criteria

Exclusion criteria: A history of gastrointestinal disease A history of liver disease Being treated with corticosteroid drugs

Design outcomes

Primary

Measure	Time frame
Height. Timepoint: The measurement will be performed at baseline and before the intervention. Method of measurement: By the meter.;Weight. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a balance scales.;Systolic & Diastolic pressure. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a Sphygmomanometer.;Abdominal circumference. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a meter.;Fasting Blood Sugar. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a Micro-plate Eliza Reader with Parsazmun kits.;Triglycerides. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a Micro-plate Eliza Reader with Parsazmun kits.;High Density Lipoprotein. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a Micro-plate Eliza Reader with Parsazmun kits.	—

Measure

Time frame

Height. Timepoint: The measurement will be performed at baseline and before the intervention. Method of measurement: By the meter.;Weight. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a balance scales.;Systolic & Diastolic pressure. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a Sphygmomanometer.;Abdominal circumference. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a meter.;Fasting Blood Sugar. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a Micro-plate Eliza Reader with Parsazmun kits.;Triglycerides. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a Micro-plate Eliza Reader with Parsazmun kits.;High Density Lipoprotein. Timepoint: Measurements will be taken at the beginning of the study before the intervention and will be repeated after 2 months and at the end of the intervention. Method of measurement: By a Micro-plate Eliza Reader with Parsazmun kits.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Shayestefar

Semnan University of Medical Sciences

m.shayestefar@semums.ac.ir+98 23 3344 1022

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026